Sommerlad Andrew, Duncan John, Lunn Michael P T, Foong Jacqueline
Division of Psychiatry, University College London, London, UK.
Department of Neurology, National Hospital for Neurology and Neurosurgery, London, UK.
BMJ Case Rep. 2015 Mar 5;2015:bcr2014208215. doi: 10.1136/bcr-2014-208215.
A 58-year-old woman presented to neuropsychiatric services with increased frequency of confusional episodes and intermittent psychotic symptoms. She had a 19-year history of atypical epileptic seizures and cognitive decline. Detailed review of history and clinical investigations revealed that she had accumulated sufficient features to meet diagnostic criteria for systemic lupus erythematosus (SLE). She had previously had lymphopenia and a malar rash; she had positive antinuclear, anti-Ro (anti-Sjögren's-syndrome-related antigen A) and anti-SM (anti-Smith Antibody) antibodies, and elevated erythrocyte sedimentation rate. The seizures, cognitive impairment and psychosis were attributable to neuropsychiatric SLE. Treatment with immune-modulating therapy, cyclophosphamide, resulted in significant improvement in subjective and objective clinical presentation. Neuropsychiatric SLE should be considered a potential differential diagnosis for patients presenting with seizures, psychotic symptoms or cognitive decline. A detailed clinical evaluation with review of the medical history and appropriate laboratory analyses allows this diagnosis to be made, and appropriate treatment to be initiated.
一名58岁女性因意识模糊发作频率增加和间歇性精神病症状前往神经精神科就诊。她有19年非典型癫痫发作和认知衰退病史。详细的病史回顾和临床检查发现,她具备了足够的特征,符合系统性红斑狼疮(SLE)的诊断标准。她既往有淋巴细胞减少和颊部皮疹;抗核抗体、抗Ro(抗干燥综合征相关抗原A)和抗SM(抗史密斯抗体)抗体呈阳性,红细胞沉降率升高。癫痫发作、认知障碍和精神病归因于神经精神性SLE。免疫调节治疗药物环磷酰胺治疗后,主观和客观临床表现有显著改善。对于出现癫痫发作、精神病症状或认知衰退的患者,应考虑神经精神性SLE作为潜在的鉴别诊断。通过详细的临床评估、病史回顾和适当的实验室分析可以做出该诊断,并开始适当的治疗。